Overall rank by patents
#1,931
Across all tracked assignees
USPTO PatentsView assignee record - 208 granted patents across 17 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Medtronic holds 208 US patents across 17 technology areas, rank #1,931 of 50,000 tracked assignees.
Medtronic Ardian Luxembourg S.a.r.l. has been granted 208 US utility patents between 2015 and 2025, placing Medtronic Ardian Luxembourg S.a.r.l. at rank #1,931 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medtronic Ardian Luxembourg S.a.r.l. is one of the more focused assignees in the PatentsView dataset. By volume, Medtronic sits between The Charles Machine Works, Inc. (209 patents, rank #1,927) and COLE HAAN Llc (207 patents, rank #1,935) - the closest US assignees by grant volume. The composite Innovation Score of 45.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 64 grants, compared with 144 in the 2015–2019 window, a -56% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Medtronic Ardian Luxembourg S.a.r.l.'s 17.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic Ardian Luxembourg S.a.r.l. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Charles Machine Works, Inc.
209 patents
Becton Dickinson France
208 patents
Fiskars Finland Oy Ab
208 patents
JT International SA
208 patents
Novozymes, Inc.
208 patents
Rain Bird Corporation
208 patents
Zephyros, Inc.
208 patents
MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
208 patents
COLE HAAN LLC
207 patents
What this shows Medtronic holds 208 patents at rank #1,931, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,931 in granted patent volume.
Other assignees with the most granted patents in Medtronic's primary technology class.
Medtronic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 33 | 15.9% |
| 2016 | 31 | 14.9% |
| 2017 | 21 | 10.1% |
| 2018 | 26 | 12.5% |
| 2019 | 33 | 15.9% |
| 2020 | 20 | 9.6% |
| 2021 | 18 | 8.7% |
| 2022 | 21 | 10.1% |
| 2023 | 3 | 1.4% |
| 2025 | 2 | 1.0% |
Top 15 of 17 technology areas
Overall rank by patents
#1,931
Across all tracked assignees
45.9 out of 100
How to use this portfolio
Medtronic's 208 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.